Fundraising Fox

ForCast Orthopedics

Denver, US · Delaware corporation · 2 known investors

ForCast Orthopedics develops treatments for periprosthetic joint infections using a proprietary targeted drug delivery platform designed to replace the standard of care. The company serves orthopedic surgeons and joint replacement patients seeking improved outcomes for this serious infection complication.

BiotechHealthtechMedical Devices

Founders & leadership

PN
Peter NoymerinExecutive Chairman and CEO
JF
Jared ForanNamed on SEC filing

Board

TO
Terry OpgenorthBoard director
CD
Charles DeCookBoard director

Investors · 2

Also in the syndicate · 2

OrthoInnovationsleadOrthoInnovations LLClead

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 1 round · 2025

▶$3.8MraisedAug 2025 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter NoymerExecutive Officer, Director
  • Jared ForanExecutive Officer, Director
  • Terry OpgenorthDirector
  • Charles DeCookDirector
Offering amount
$10M
Amount sold
$3.8M
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Read the Press Release3 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Sparta Biomedical3 shared keywordsSparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology. The company targets treatment of joint cartilage degeneration and osteoarthritis through cartilage-like implants for joints such as the great toe.

Companies competing with ForCast Orthopedics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2020$1.2M
National Science FoundationPhase I2019$224.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

ForCast Orthopedics Announces Initial Close of Series a Financing Round to Advance Novel Therapies for PJI - BioSpacebiospace.com · Aug 2025ForCast Orthopedics Secures Series A Funding to Advance Novel Periprosthetic Joint Infection Therapiestrial.medpath.com · Aug 2025ForCast Orthopedics Holds Initial Close of Series A Financingfinsmes.com · Aug 2025

Frequently asked questions

What does ForCast Orthopedics do?
ForCast Orthopedics develops treatments for periprosthetic joint infections using a proprietary targeted drug delivery platform designed to replace the standard of care. The company serves orthopedic surgeons and joint replacement patients seeking improved outcomes for this serious infection complication.
How much funding has ForCast Orthopedics raised?
ForCast Orthopedics has disclosed $3.8M raised across 1 round.
Where is ForCast Orthopedics headquartered?
ForCast Orthopedics is headquartered in Denver, US.